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commenced during his stay in Lourenl;<> Marques in the last week
of January 1948. Three weeks before his return from Louren~o
Marques he developed fever. Mter his return to Johannesburg
he was admitted to the Coronation Hospital on 11 March with
pyrexia which lasted 2 days. The spleen was palpable and soft,
but not tender. A blood smear showed the presence of spiro-
chaetes of relapsing fever. The patient had most likely become
infected in Louren~o Marques.
In addition to these cases, 5 blood smears from
Europeans positive for relapsing-fever spirochaetes
have in the last 20 years come to the notice of Dr. S.
Annecke 7 of the Union Health Department, Tzaneen.
Details of these cases are not available except that they
represent 3 men and 2 women all from the Pietersburg
district.
The total of 23 cases of relapsing fever over a period
of 23 years reflects a very small infection rate in Euro-
peans. The possibility that other cases have in fact
occurred but remained undiagnosed cannot of course
be excluded.
Physicians should consider relapsing fever in differen-
tial diagnosis in the areas shown in the map as well
as in adjoining regions in any patient with a recurrent
type of temperature, and should attempt to confirm
its presence by the examination of blood smears taken
at the height of the temperature or enlist laboratory
aid for a complement-fixation test on the patient's
blood-serum.
SUMMARY
Relapsing fever transmitted by the Ornithodorus moubata
tick occurs mainly in the northern and eastern parts
of the Union of South Africa bordering the countries
where the disease is endeInic, and also in the semi-arid
central regions through Kimberley and Graaff-Reinet.
The infection rate in Europeans in South Africa from
relapsing fever (tick-borne) is very low; only 23 cases
are on record as having occurred in the last 23 years.
Other cases in Europeans may have escaped notice,
and physicians in the endeInic areas are well advised
to bear in mind the possibility of a diagnosis of relapsing
fever in cases where pyrexia in a patient is unexplained.
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DERMATITIS HERPETIFORMIS TREATED WITH DIAMINO-
DIPHENYLSULPHONE (DADPS)
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Dermatitis herpetiforrnis is a chronic skin disease of
unknown aetiology, characterized by intense itching
and the presence of grouped erythematous, papulo-
vescular, vesicular and bullous lesions, which on in-
volution leave pigmented spots and sometimes scars.
The disease, which may persist for 10 years or more,
has natural reInissions and exacerbations.
There is no cure for the disease, but there are several
well-tried drugs which control both the rash and the
itching. Arsenic was probably the first of these drugs
to be used, given either as liquor arsenicalis or as acetar-
sone. The disadvantage o( arsenic is its toxicity, par-
ticularly when administered over prolonged periods.
Arsenical keratoses with their tendency eventually to
develop into. squamous epitheliomata are a real hazard
to the patient taking arsenic.
Sulphapyridine is also effective in controlling der-
matitis herpetiformis, and has probably been the most
widely-used drug in this condition. It is, however the
most toxic of the sulphonamides, and because of an
jdiosyncrasy to it, many patients are unable to con-
tinue treatment. The treatment of the patient who is
unable to take tills drug is a difficult problem, and
any drugs which are reputed to control the disease are
worthy of trial.
SULPHONES
The sulphones, a group of drugs which have been used
for some years in the treatment of leprosy and tubercu-
losis, have also recently been used with good effects in
dermatitis herpetiforrnis.1 • 2 Cornbleet 2 has treated
13 cases of dermatitis herpetiforrnis with diasone with
excellent results; some of these cases were refractory to
other treatment, including sulphapyridine. Since it is
thought that the more complex sulphones act by liberat-
ing diaInino-diphenysulphone (DADPS) in the body,
it was considered logical to investigate the effect of
DADPS on dermatitis herpetiformis, particularly since
it has been held by some to be superior to sulphapyri-
dine in controlling the condition. 3 DADPS is better
absorbed from the gastro-intestinal track than the
more complex suIphones, and blood levels are better
maintained with it, since it is the most slowly eliminated
of the sulphone compounds.
Toxic effects from its use in leprosy and tuberculosis
-include dermatitis, lepra reactions, leprous neuritis and
iritis. Haemolytic and hypochromic anaeInia have
also been recorded, as well as jaundice due to hepatitis.
The commonest side-effect of sulphone therapy is a
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transient normocytic anaemia, which appears during
the first few weeks of treatment but clears spontaneously
in spite of continued sulphone therapy. Other 'blood
changes include methaemoglobinaemia, which occurred
in half of the patients treated by Cornbleet with diasone.
The first cases selected for treatment were those
patients unable to tolerate sulphapyridine therapy
because of nausea and vomiting or severe leuko-
penia. Other cases were included in the trial
because they did not respond to sulphapyridine therapy
and the control of the rash and itching had become a
difficult therapeutic problem. The result of this therapy
in the first few cases was so impressive that it was
decided to treat cases well controlled with sulpha-
pyridine, in order to compare the efficiency of the
latter with that of DADPS.
CASE REPORTS
Case I. H.W., female aged 53 years, suffering from dermatitis
herpetiformis since May 1952. She was first seen in August 1952,
when she was treated with sulphapyridine, 0·5 g. r.d.s. .This
relieved the irritation, but could not be continued because of
nausea, vomiting and weakness. She then under.vent various
treatments, including liquor arsenicalis, nicotinamide and anti-
histaminics, with no marked effect. On 5 March 1954 she was
started on DADPS, 50 mg. daily, with marked improvement.
Two weeks later the dosage was decreased to 50 mg. every second
or third day. She has shown no toxic effects and remains com-
pletely free of rash and itching. The blood count and haemoglobin
level remains normal.
Case 2. E.H., male aged 38 years, suffering from dermatitis
herpetiformis since 1947. He was first treated with sulphapyridine
in November 1950, with marked subjective and objective improve-
ment, but had to be discontinued after several weeks because
the patient developed an acute tonsilitis associated with a leu-
kO{>enia (white-cell count 3,000 per c.mm., with differential count:
polymorphs 54 %, Iymphocytes 36 %, monocytes 8 %, band forms
2 %). In November 1954 sulphapyridine, 0·5 g. daily, was again
given, and in 2 weeks the white cell count fell from 7,000 per
c.mm. to 3,000 per c.mm. (normal differential counts). Sulpha-
pyridine was therefore again discontinued. On 15 February 1954
he was put on 50 mg. daily. He was seen again after 2 weeks,
when there were no signs of active disease and pruritus had dis-
appeared. Because of a relapse, .the dosage was later increased
to 100 mg. daily, which completely controls the disease. He
shows no toxic effects, and the blood count remains normal.
Case 3. J.P., female aged 2,t years. First seen on 14 February
1954 with a 2 weeks' history of a rash. There are 5 other children
in the family, none with any skin disease. The rash was typical
of dermatitis herpetiformis, with blisters and bullae showing an
annular arrangement. It affected the vulva, thighs, back, face and
limbs. She was first treated with sulphapyridine 0·5 g. daily
as an out-patient, but there was no response to treatment and she
was therefore admitted to hospital. Here, in spite of continued
sulphapyridine therapy and liquor arsenicalis, she did not improve.
On 27 March 1954 DADPS 25 mg. daily, was given, with improve-
ment noticeable after 3 days of treatment. She developed a micro-
cytic anaemia while on' this dosage, but this has improved and
continues to improve though the drug is still taken. The rash
is not completely controlled on this dosage, and she still develops
new bullae, but whenever the drug is discontinued a very severe
relapse occurs. She has shown no serious toxic effects. though
on occasions she has had as much as 50 mg. of DADPS a day.
Case 4. J.R., male aged 50 years, suffering from dermatitis
herpe!iformis for the last 2 years. He had been treated for the
past 18 months with sulphapyridine, 3 g. daily. The rash had
fluctuated during this period without complete freedom from
itching and active signs of disease. He had a past history of a
perforated duodenal ulcer in 1943, gastrectomy in 1948, and
haematemesis after aspirin in 1951. On 10 February 1954 he still
showed active lesions of dermatitis herpetiformis on the elbows,
scratched papules, scars and erythema on the sacrum. General
examination showed no abnormality. Blood-eount normal.
He was admitted to hospital and given inert tablets (calcium
lactate) for 3 days with no effect on the rash. He was then treated
with DADPS 100 mg. daily, and showed remarkable subjective
and objective'improvement. He continues to take DADPS daily,
with excellent control of the rash.
Case 5. H.C., male aged 36 years, suffering for the last 3 years
from dermatitis herpetiformis, which had been fairly well con-
trolled by sulphapyridine, I g. 3 times a day, though the patient
still had active disease as shown by itching and the presence of
vesicles. On 6 April 1954 tjl.e sulphapyridine was discontinued
and DADPS 50 mg. dailv substituted. On this dosage he de-
velooed a severe relapse and the dosage was increased 1 week
later to 100 mg. daily, but this was insufficient to control the
itching and the eruption. On 20 April treatment was then changed
back to 3 g. of sulphapyridine a day, which again controlled the
rash. On 27 April the sulphapyridine was again stopped and
DADPS given, 200 mg. a day. The rash is very well controlled
on this dosage. though he still shows vesicles. He states that he
much prefers DADPS because of the greater relief of itching.
Haemoglobin 80%, and examination of the blood shows methae-
mOldobinaemia.
Case 6. J.B., male aged 63 years, suffering for 7 years from
typical dermatitis herpetiformi~ affecting the shoulders, elbows
and scalp, and with marked pIgmentatIOn o~ the skID over the
sacrum. On 29 April 1954 DADPS, 100 mg. daily, was commenced
with complete relief from itching and no signs of active disease
after 2 weeks of treatment. He continues to take 100 mg. DADPS
a day for complete control of the eruption. There is no anaemia
and no toxic effects from DADPS have occurred.
Case 7. M.A., female aged 31 years, with dermatitis herpeti-
formis of 4 years' duration. Since February 1951 she had been
treated with sulphapyridine, 2 g. daily, but without complete
control of the rash or itching. On 29 March 1954 DADPS, 50 mg.
daily was commenced and by 5 April 1954 she .was markedly
improved; 'the blood count remained normal. On 13 May 1954,
DADPS was increased to 100 mg. a day because of the presence
-of active lesions. In spite of the presence of new lesions, she
states that the itching has completely disappeared and 'I can sleep
now'. She has shown no toxic effects.
Case 8. L.W., male aged 36 years, with very severe dermatitis
herpetiformis for the last 7 years. Attempts had been made to
control the rash with sulphapyridine, but these had been dis-
continued because of severe relapses. He had also lmdergone
prolonged treatment with liquor arseni<;alis, which was discon-
tinued when the patient developed arsenical keratoses of the
palms. Thereafter he had had antihistaminics, nicotinamide and
suramin. In January 1954 DADPS 50 mg. daily was commenced,
which soon relieved the itching. The dose was increased after
3 weeks to 100 mg. a day. The patient stated that this treatment
had been more effective in relieving the itching than any of·the
previous treatments, though he still showed severe active skin
lesions. This patient suffered also from bronchiectasis, mitral
stenosis with congestive cardiac failure, chronic nephritis and
arsenical keratoses. On 13 May 1954 he became jaundiced and
showed severe cardiac failure. Though there were signs of active
dermatitis herpetiformis, he had very little itching. He died on
18 Mav 1954.
Case- 9. A.B., male aged 34 years, with 3 years' history of der-
matitis herpetifortnis. He had undergone various treatments
including liquor arsenicalis, suramin, nicotinic acid and sulpha-
pyridine. The-rash was comparatively well controlled by sulpha-
pyridine, 2 g. daily. On 10 March 1954 treatment was changed
to DADPS, 100 mg. daily, later iecreased to 150 mg. a day. The
patient states that he feels much better on these tablets and sleeps
better because of the absence of itching. He continues to take
150 mg. daily as a maintenance dose and has shown no toxic
effects.
Case 10. S.E., male aged 42 years, with dermatitis herpetifortnis
of 2 years' duration controlled only moderately well by 2 ·5 g. of
sulphapyridine daily. On 9 April 1954 DADPS, 50 mg. daily,
was substituted and he relapsed within a few days, so that the
sulphapyridine was again given in the same dosage. On 7 May
1954 he still had active vesicles, and 200 mg. of DADPS daily
was commenced. This produced complete control of the rash and
itching. He shows no active disease after 3 months on 200 mg.
daily as a maintenance dose. He much prefers these tablets to
sulphapyridine, as the latter made him feel 'off colour'. His
blood-eount remains normal. He has shown no toxic effeCts.
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Case 11. A.B., male aged 37 years, seen on 9 April 1954 with
a 4 months' history of typical dermatitis herpetiformis affecting
the beard, axillae, elbows and sacral area. He was given sulpha-
pyridine 2 g. daily with marked relief, both objective and sub-
jective. On 21 May 1954, in spite of the sulphapyridine he had
relapsed,and DADPS, lOO mg. daily, was substituted. His rash
has virtually cleared, with complete disappearance of itching.
Case 12. E.S., male aged 67 years, with 8 years' duration of
rash very well controlled by sulphapyridine, 0·5 g. every alternate
day, though occasional itching and vesicles were present. On
7 May 1954 treatment was changed to DADPS 100 mg. daily.
By 21 May the raSh was still well controlled. The patient states
that as far as he is concerned there is no difference between these
tablets and the previous ones. He continues to take DADPS
50 mg. daily as a maintenance dose. His blood-count and haemo-
globin remain normal. .
Case 13. e.W., male aged 51 years, with dermatitis herpeti-
formis for the last 15 years. He had undergone occasional arsenical
therapy and since 1951 had taken 0'5 g. of sulphapyridine daily.
On 30 April 1954 he still showed active signs of disease. The
sulphapyridine was stopped and DADPS, 100 mg. daily, given.
The relief of itching is more complete than with sulphapyridine.
He continues to take this dose to control the rash. He has shown
no toxic e.ffects.
Case 14. E.G., female aged 63 years, first seen in August 1952
with typical dermatitis herpetiformis. From that time she had
been on sulphapyridine, 1·5 g. daily, with comparative comfort
and control of the rash. On 6 May 1954 sulphapyridine was
stopped. and 3 days afterwards she developed a severe relapse.
DADPS 100 mg. daily was started on 20 May 1954 with good
control of the rash and itching. She continues on this dosage.
The rash is well controlled and no toxic effects have occurred.
Case 15. D.S., male aged 37 years, with rash since 1949. He
had been on liquor arsenicalis, 2 m. I.d.s., for one year. In 1950
treatment was changed to sulphapyridine 3 g. daily with no marked
response. In April 1954 he was seen with active vesicles, papules,
and itching. DADPS was given, lOO mg. a day, and 2 weeks
later there was no itching and no signs of any activity. He was
last seen on 15 July 1954, when he was taking 25 mg. daily for
complete control of the rash. He has shown no toxic effects.
Case 16. W.S., male aged 45 years, with dermatitis herpeti-
formis since 1947. Treated for 2 years with liquor arsenicalis,
3 m. I.d.s. He developed severe relapses when ~rsenic was stopped.
Since January 1949 he has been treated with sulphapyridine
0·5 g. daily. On 14 June 1954 his haemoglobin was 80%, colour
index I '0, and white-cell count 5,000 c.mm., with a normal differ-
ential count. DADPS, 200 mg. daily, was then' substituted for
sulphapyridine. and 6 weeks later there was no itching and COI11-
plete control of the rash. The patient prefers this treatment to
any preVious one'. There was no change in the blood-counts after
6 weeks of treatment: no abnormal pigments were found on
spectroscopic examination of the blood.
Case 17. EH., male aged 47 years. Since 1950 this patient
suffered from typical dermatitis herpetiformis not fully controlled
by sulphapyridine, I ·5 g. daily. He was seen on 31 May 1954
with active lesions on the back and scalp, when treatment was
changed to DADPS, 100 mg. daily. On 10 June 1954 his haemo-
globin was 73 ~.{, colour index 0 '87, and white cell count 7,000
c.mm., with a normal differential count. DADPS therapy was
continued. On 28 June 1954 haemoglobin was 95%. faecal urobi-
linogen was normal, and examination of the blood showed methae-
moglobin present; fragility of the red cells normal. Both the patient
and his relatives were alarmed at his appearance, which was due
to methaemoglobinaemia, but they were reassured and he agreed
to continue treatment. On 5 July 1954 he still had a peculiar
colour due to methaemoglobinaemia, but his relatives were no
longer Concerned about his appearance. His rash remains well
controlled on 100 mg. of DADPS a day.
Case 18. E.1., male aged 57 years, with dermatitis herpetiformis
of 5 years' duration, only partially controlled by sulphapyridine
and later by liquor arsenical is. When seen on 12 May 1954 he
showed active lesions on the scalp, and DADPS, lOO mg. daily,
was prescribed. On 29 July 1954 he had no itching, no signs of
any activity, and no toxic effects. He continues to take 100 mg.
a day as a maintenance dose.
Case 19. F.e., male aged 69 years, with 3 years' history of rash
well controlled with sulphapyridine, I g. daily. On 10 June 1~54
his blood count showed an eosinophilia, and the haemoglobin
was 102~;';. DADPS, 200 mg. daily, was given. On 21 June 1954
he complained of a constant headache, he was very cyanosed
and blood examination showed sulphaemoglobinaemia. All
treatment was stopped. By 10 July 1954 his cyanosis had dis-
appeared, but the rash had relapsed. DADPS lOO mg. daily was
given, and on 26 July 1954 the patient again complained of severe
headaches. He was again cyanosed, and sulphaemoglobin was
again present on spectroscopic examination of the blood. The
DADPS was continued and ascorbic acid, 900 mg. daily, was given.
As the cyanosis persisted on this treatment, the DADPS was
discontinued.
RESULTS OF TREATME T
The 19 cases of dermatitis herpetiformis treated with
DADPS include one case of the infantile type of the
disease. All these cases responded to treatment. The
relief Of itching and the disappearance of the rash was
quite dramatic in most cases. The dosage of DADPS
appears to be directly proportional to the dosage of
sulphapyridine necessary to control the eruption. No
case required more than 200 mg. of DADPS a day to
control the rash, the average maintenance dose being
100 mg. a day. As with sulphapyridine, relapses gener-
ally occur on the 3rd day after the patient discontinues
treatment. Since the disease is characterized by spon-
taneous remissions and exacerbations, patients were
told to modify their dosage as they found necessary.
Only one patient (case 12) noted no difference between
DADPS therapy and sulphypyridine. All the other
patients preferred DADPS therapy because of the
greater relief from itching and the absence of side
effects.
TOXIC EFFECTS
Kruizinga and Ham"rninga 3 noted no severe toxic
effects in their 12 cases, nor were there any present in
our 19 cases.
One patient (case 19) was obliged to discontinue
treatment because of.sulphaemaglobinaemia associated
with severe headaches. This did not respond to big
doses of ascorbic acid, so DADPS was discontinued.
Two cases showed methaemoglobinaemia. These
continued with their DADPS therapy and had no other
toxic effect from this drug.
One patient (case 8) when first seen, was very ill,
suffering from bronchiectisis, mitral stenosis and
chronic nephritis. Though he obtained substantial
relief of itching from DADPS, he continued to show
large numbers of vesicles and blisters. This may have
been due to insufficient dosage of the drug, and the
continued absorption of iodine from the lipiodol in his
bronchiectatic cavities. Though he was jaundiced for
2 weeks before his death, the jaundice could not be
attributed definitely to the DADPS.
DISCUSSION
The mode of action of DADPS in dermatitis herpeti-
formis is unknown. The more complex suIphones, e.g.
diasone and sulphatrone 1, 2 have been used in the
treatment of dermatitis herpetiformis with favourable
results, though their action is generally inferior to that
of sulphapyridine. As these more complex sulphones
are thought to be broken down in the body to DADPS,
/
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it is understandable that DADPS should also have a
favourable action in derinatitis herpetiformis.
SUMMARY
Nineteen cases of dermatitis herpetiformis were treated
with DADPS for an average period of 3t months.
All cases responded to treatment provided dosage was
sufficient. The relief of itching and the control of the
rash is more pronounced with DADPS than with
sulphapyridine.
I wish to thank Drs. H. R. Vickers, 1. Sneddon, D. FIetcher,
R. Church and M. McElligott of the Rupert Hallam Department
of Dermatology, Royal Infirmary, Sheffield, for access to their
cases and for their advice.
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THORACIC OESOPHAGEAL DIVERTICULUM
WILLEM P. STEENKAMP, JNR.
Surgeon, Cape Town
This is neither an article on a known though com-
paratively uncommon condition nor a report on a
series of cases. The case reported however presents
etiological and clinical features that warrant reporting it.
Oesophageal diverticula are classified into pharangeal,
thoracic and epiphrenic according to locality. Etio-
logically again they are divided into traction or pulsion
depending on the causative factor present. 'Boyd l thus
stresses the point that, as in hernias and aneurysms
the diverticulum owes its origin to pressure from within
or traction from without.
To the writer's mind this theory holds good for
pulsion only in the case of cervkal (pharangeal) diver-
ticula, since in that region no traction is present.
Thoracic oesophageal diverticula, i.e. those below
the bifurcation of the trachea, are usually due to trac-
tion exerted by old tubercular lesions, whereas epi-
phrenic ones, i.e. those just above the diaphragm, are
true pulsion diverticula due to obstructed deglutition
caused by cardiospasm, or a low oesophageal obstruc-
tion caused by the scar tissue resulting from syphilis,
tuberculosis, or a high gastric ulcer involving the oeso-
phageal entrance into the stomach. These diverticula
are small-often multiple. Lindskay and Liebow2
consider an already existing weakness of the oeso-
phageal wall as the main causative factor. Sellors3
states that although pulsion diverticula are fairly com-
mon phenomena they practically always occur at the
upper end of the oesophagus, being so rare in other
parts of the oesophagus that they can safely be dis-
regarded.
Mogendie 4 found 10% of oesophageal diverticula
to be thoracic but does not state whether these cases
were mid-thoracic, like the case presently to be described,
. or epiphrenic. Lahey and Warren" report that out
of a series of 374 cases there occurred 9 epiphrenic
pulsion diverticula. Here again a truly thoracic one is
not mentioned.
The case to be reported was interesting etiolotically
in that it conformed to neither of the etiological theories
advanced by the aforementioned authors. There was
no pulsion or traction factor present, nor was there
a history or clinical evidence of lues or tuberculosis
or obstruction lower down. Professor Saint6 however
advanced the very interesting theory that where there
has been a large intake of alcohol over a prolonged
period of time an inflammatory reaction of the nerve
supply of the oesophagus sets in. There is a resulting
weakness of the oesophageal musculature followed by
diverticulum formation. The case reported conforms to
this theory.
CASE HISTORY
K. was kindly referred to me by Dr. P. Brink. The
patient was complaining of a continuous feeling of
nausea followed by copious vomiting approximately
2 hours after a meal. Two years previously he had only
noticed epigastric discomfort, but the condition had
deteriorated till he now was forced to seek medical
advice.
The past history was good except for an intake of
alcohol well above usual extending over the past 6 or
7 years. There were no serious illnesses or operations.
Physical examination revealed a fairly well nourished
male aged 46 years. Except for slight deafness all the
other findings were within normal limits.
Considering his age and the symptoms complained
of, peptic pathology was the first consideration and he
was referred to Drs. Le Roux and McCallum for a
barium meal. Only one plate of an excellent series of
pre-operative films is here reproduced (Fig. 1) and the
diverticulum is shown to be mid-thoracic, that is to
say the ostium, although oIVing to its size the belly is
practically resting on the diaphragm and partly posterior
to the heart, is just below the bifurcation of the trachea.
Operative treatment was decided on. Since the
blood supply of the oesophagus is none too copious
it was difficult to decide on the best operative approach,
since simple extirpation would leave a very wide defect
in the oesophagus and thus a great possibility of post-
operative sloughing of the suture line with the com-
plications following an intrathoracic leakage.
A very feasible alternative would be anastomosis
of the diverticular pouch through the diaphragm with
the stomach. This would be fairly easy technically
